South Korea’s Biosimilars Industry Poised to Grow Domestically and Abroad

Published date16 June 2016
Law FirmGoodwin
Subject MatterBiosimilars,Pharmaceutical Industry,Prescription Drugs,Research and Development,South Korea

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT